CALYPTE BIOMEDICAL CORP - Recent Material Event

Item 5.02             Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
(c)           On April 24, 2012, Kartlos Edilashvili, a member of the registrant’s Board of Directors, was elected as the Chief Financial Officer and Secretary of the registrant, replacing Adel Karas, who will continue as the registrant’s Chairman of the Board of Directors, President and Chief Executive Officer. Mr. Edilashvili will receive a salary of $1.00 per year in his position. Mr. Edilashvili has served as a Vice President of the registrant, currently based in Dubai, U.A.E. and previously in Geneva, Switzerland, since August 2007. From 2005 to 2007 he was a Senior Technical Advisor of WAPMERR in Geneva. Prior thereto, he served as First Secretary for the Embassy of Georgia in Geneva. Mr. Edilashvili holds an MA in finances from Tbilisi State University in Georgia.
 
SIGNATURES

Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:    April 27, 2012
 
  Calypte Biomedical Corporation  
       
       
       
  By: /s/ Adel Karas   
    Adel Karas  
    President and Chief Executive Officer